Citadel Advisors’s MIRA Pharmaceuticals MIRA Stock Holding History
Bought
Maintained
Sold
Other funds holding MIRA
CSI
FAB
Citadel Advisors's MIRA Position: Q2 2026 in Review
Citadel Advisors opened a new position in MIRA Pharmaceuticals (MIRA) in Q2 2026: 18,661 shares worth $17.7K. The stake represents ﹤0.01% of the portfolio and ranks #13428 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in MIRA as recently as Q4 2024.
Citadel Advisors first reported a position in MIRA in Q2 2024 and has held it in 3 quarters since. The position peaked at $112K in Q4 2024. 26 funds tracked by Wall St. Rank hold MIRA as of Q2 2026.
- Citadel Advisors held 18,661 shares of MIRA Pharmaceuticals worth $17.7K as of Q2 2026.
- MIRA Pharmaceuticals was a new Citadel Advisors position in Q2 2026.
- MIRA Pharmaceuticals made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13428 holding.
- Citadel Advisors first reported a position in MIRA Pharmaceuticals in Q2 2024 and has held it in 3 quarters since.
- Citadel Advisors's MIRA Pharmaceuticals position peaked at $112K in Q4 2024.
- 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.